Business Context and Reporting Period
Immunocore Holdings Plc (IMCR) filed a Form 8-K on May 8, 2024, to announce financial results for the first quarter ended March 31, 2024. The filing incorporates a press release (Exhibit 99.1) detailing these results and recent corporate updates.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the press release furnished as Exhibit 99.1, which is not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that such results were announced in the referenced press release.
Guidance, Outlook, and Risks
The filing mentions "other recent corporate updates" alongside the financial results but does not explicitly detail guidance, outlook, management commentary, risks, contingencies, or unusual items within the provided text. The document notes that the information in Item 2.02 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 8, 2024) for specific Q1 2024 financial figures.
- Verify the details of "recent corporate updates" mentioned in the filing.
- Confirm the status of the American Depositary Shares (ADS) and ordinary shares listed on The Nasdaq Stock Market LLC.
- Check for any subsequent filings that may incorporate the furnished information by reference.